Read the January/February 2020 edition of Pharmafocus online now!
pharmafile | January 30, 2020 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | NHS, UK, US, brexit, coronavirus, opioid crisis, pharma
Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got done – or at least, the first step in a long process – and the UK will leave the European Union at 11pm on 31 January.
It’s a path paved with uncertainty, but it does provide clarity for business and industry which have been previously unable to plan ahead in such a divided climate. But the challenges ahead will be great, and are embodied in the news that NHS waiting times have now hit the worst level ever recorded.
But if you can’t get enough of the continuing drama of Brexit, you don’t need to wait long until the next seismic political event; the US Presidential Election is looming in November, and the Democratic Party will name its nominee for the presidency in July, a decision that will set the stage for a showdown with sitting President Donald Trump on key issues like drug pricing and the opioid crisis.
These issues will be of the utmost importance to voters in a climate where the tightening grip of conspiracy theories and anti-vaccine disinformation has caused measles rates to rocket to its highest rate in 27 years. In a special feature, Pharmafocus looks at each of the presidential candidates and their plans to tackle the opioid epidemic.
Elsewhere in the issue, we document the first chapters of the ongoing Wuhan coronavirus outbreak, cover the latest wave of drug price hikes from Big Pharma in the US, and examine why the WHO is warning that efforts against antimicrobial resistance are under threat.
This month, we also welcome Conor Kavanagh, who has joined the Pharmafocus team as Editorial Assistant/Journalist.
Related Content
NICE recommends migraine treatment for NHS use
The National Institute for Health and Care Excellence (NICE) has shared draft guidance recommending AbbVie’s …
Amgen opens new biomanufacturing facility in Ohio, US
Amgen has announced that it has opened a new manufacturing site in Central Ohio, US. …
Novo Nordisk launches Wegovy in the UK
Novo Nordisk has today announced that Wegovy (semaglutide injection) is now available in the UK …
